Global Pharmacogenomics Market Size, Share, and COVID-19 Impact Analysis, By Technology (DNA Sequencing, Microarray, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, and Others), By Application (Drug Discovery, Neurology, Oncology, Pain Management, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Analysis and Forecast 2022-2030
Table Of Contents
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Component
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key Trends
3.2.1. Increasing Expenditure in R&D Propel Market Growth
3.3. Market Drivers
3.3.1. Increasing Inorganic Growth Methods Drive Market Growth
3.3.2. Rising Focus on Precision Medicine
3.4. Market Restraints
3.4.1. Lack of Well-Trained and Technically Skilled Professionals
3.5. Market Opportunities
3.5.1. Lucrative Opportunities in the Emerging Economies
3.6. Market Challenges
3.6.1. Complexities in Finding the Right Gene Affecting the Drug Response
3.7. Porter’s Five Forces Analysis
3.7.1. Bargaining Application of Suppliers
3.7.2. Bargaining Application of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Pharmacogenomics Market
Chapter 5. Global Pharmacogenomics Market Overview, By Technology, 2017 – 2030 (USD Million)
5.1. Global Pharmacogenomics Market Share, By Technology, 2017 - 2030 (USD Million)
5.1.1. DNA Sequencing
5.1.1.1. Market Size and Projections,2017 - 2030 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
5.1.2. Microarray
5.1.2.1. Market Size and Projections,2017 - 2030 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
5.1.3. Polymerase Chain Reaction
5.1.3.1. Market Size and Projections,2017 - 2030 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
5.1.4. Electrophoresis
5.1.4.1. Market Size and Projections,2017 - 2030 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
5.1.5. Mass Spectrometry
5.1.5.1. Market Size and Projections,2017 - 2030 (USD Million)
5.1.5.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
5.1.6. Others
5.1.6.1. Market Size and Projections,2017 - 2030 (USD Million)
5.1.6.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
Chapter 6. Global Pharmacogenomics Market Overview, By Application, 2017 - 2030(USD Million)
6.1. Global Pharmacogenomics Market Share, By Application, 2017 - 2030 (USD Million)
6.1.1. Drug Discovery
6.1.1.1. Market Size and Projections,2017 - 2030 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
6.1.2. Neurology
6.1.2.1. Market Size and Projections, 2017 - 2030 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
6.1.3. Oncology
6.1.3.1. Market Size and Projections, 2017 - 2030 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
6.1.4. Pain Management
6.1.4.1. Market Size and Projections, 2017 - 2030 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
6.1.5. Others
6.1.5.1. Market Size and Projections, 2017 - 2030 (USD Million)
6.1.5.2. Market Size and Projections, by Region, 2017 - 2030 (USD Million)
Chapter 7. Global Pharmacogenomics Market Overview, By Geography, 2017 - 2030(USD Million)
7.1. Global Pharmacogenomics Market Share, By Geography, 2017 - 2030(USD Million)
7.1.1. Market size and projections, by Countries, 2017 - 2030 (USD Million)
7.1.2. Market Share and CAGR Comparison, by Countries, 2021 - 2030 (%)
Chapter 8. North America Pharmacogenomics Market Overview, By Countries, 2017 - 2030(USD Million)
8.1. North America Pharmacogenomics Market Overview, 2017 - 2030 (USD Million)
8.1.1. Market Size and projections, 2017 - 2030 (USD Million)
8.1.2. North America Pharmacogenomics Market Overview, By Technology, 2017 - 2030 (USD Million)
8.1.3. North America Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
8.1.4. North America Pharmacogenomics Market Overview, By Countries, 2017 - 2030 (USD Million)
8.1.4.1. U.S. Pharmacogenomics Market Overview, 2017 - 2030 (USD Million)
8.1.4.1.1. Market Size and projections, 2017 - 2030 (USD Million)
8.1.4.1.2. U.S. Pharmacogenomics Market Overview, By Technology, 2017 - 2030 (USD Million)
8.1.4.1.3. U.S. Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
8.1.4.2. Canada Pharmacogenomics Market Overview, 2017 - 2030 (USD Million)
8.1.4.2.1. Market Size and projections, 2017 - 2030 (USD Million)
8.1.4.2.2. Canada Pharmacogenomics Market Overview, By Technology, 2017 - 2030 (USD Million)
8.1.4.2.3. Canada Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
8.1.4.3. Mexico Pharmacogenomics Market Overview, 2017 - 2030 (USD Million)
8.1.4.3.1. Market Size and projections, 2017 - 2030 (USD Million)
8.1.4.3.2. Mexico Pharmacogenomics Market Overview, By Technology, 2017 - 2030 (USD Million)
8.1.4.3.3. Mexico Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
Chapter 9. Europe Pharmacogenomics Market Overview, By Countries, 2017 - 2030(USD Million)
9.1. Europe Pharmacogenomics Market Overview, 2017 - 2030 (USD Million)
9.1.1. Market Size and projections, 2017 - 2030 (USD Million)
9.1.2. Europe Pharmacogenomics Market Overview, By Technology, 2017 - 2030 (USD Million)
9.1.3. Europe Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
9.1.4. Europe Pharmacogenomics Market Overview, By Countries, 2017 - 2030 (USD Million)
9.1.4.1. Germany
9.1.4.1.1. Market Size and projections, 2017 - 2030 (USD Million)
9.1.4.1.2. Germany Pharmacogenomics Market Overview, By Technology, 2017 - 2030(USD Million)
9.1.4.1.3. Germany Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
9.1.4.2. France
9.1.4.2.1. Market Size and projections, 2017 - 2030 (USD Million)
9.1.4.2.2. France Pharmacogenomics Market Overview, By Technology, 2017 - 2030(USD Million)
9.1.4.2.3. France Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
9.1.4.3. UK
9.1.4.3.1. Market Size and projections, 2017 - 2030 (USD Million)
9.1.4.3.2. UK Pharmacogenomics Market Overview, By Technology, 2017 - 2030(USD Million)
9.1.4.3.3. UK Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
9.1.4.4. Italy
9.1.4.4.1. Market Size and projections, 2017 - 2030 (USD Million)
9.1.4.4.2. Italy Pharmacogenomics Market Overview, By Technology, 2017 - 2030(USD Million)
9.1.4.4.3. Italy Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
9.1.4.5. Spain
9.1.4.5.1. Market Size and projections, 2017 - 2030 (USD Million)
9.1.4.5.2. Spain Pharmacogenomics Market Overview, By Technology, 2017 - 2030(USD Million)
9.1.4.5.3. Spain Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
9.1.4.6. Rest of Europe
9.1.4.6.1. Market Size and projections, 2017 – 2030
9.1.4.6.2. Rest of Europe Pharmacogenomics Market Overview, By Technology, 2017 - 2030(USD Million)
9.1.4.6.3. Rest of Europe Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
Chapter 10. Asia Pacific Pharmacogenomics Market Overview, By Countries, 2017 - 2030 (USD Million)
10.1. Asia Pacific Pharmacogenomics Market Overview, 2017 - 2030 (USD Million)
10.1.1. Market Size and projections, 2017 - 2030 (USD Million)
10.1.2. Asia Pacific Pharmacogenomics Market Overview, By Technology, 2017 - 2030 (USD Million)
10.1.3. Asia Pacific Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
10.1.4. Asia Pacific Pharmacogenomics Market Overview, By Countries, 2017 - 2030 (USD Million)
10.1.4.1. India
10.1.4.1.1. Market Size and projections, 2017 - 2030 (USD Million)
10.1.4.1.2. India Pharmacogenomics Market Overview, By Technology, 2017 - 2030(USD Million)
10.1.4.1.3. India Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
10.1.4.2. China
10.1.4.2.1. Market Size and projections, 2017 - 2030(USD Million)
10.1.4.2.2. China Pharmacogenomics Market Overview, By Technology, 2017 - 2030(USD Million)
10.1.4.2.3. China Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
10.1.4.3. Japan
10.1.4.3.1. Market Size and projections, 2017 - 2030 (USD Million)
10.1.4.3.2. Japan Pharmacogenomics Market Overview, By Technology, 2017 - 2030(USD Million)
10.1.4.3.3. Japan Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
10.1.4.4. South Korea
10.1.4.4.1. Market Size and projections, 2017 - 2030(USD Million)
10.1.4.4.2. South Korea Pharmacogenomics Market Overview, By Technology, 2017 - 2030(USD Million)
10.1.4.4.3. South Korea Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
10.1.4.5. Rest of Asia Pacific
10.1.4.5.1. Market Size and projections, 2017 - 2030 (USD Million)
10.1.4.5.2. Rest of Asia Pacific Pharmacogenomics Market Overview, By Technology, 2017 - 2030(USD Million)
10.1.4.5.3. Rest of Asia Pacific Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
Chapter 11. Middle East & Africa Pharmacogenomics Market Overview, By Countries, 2017 - 2030 (USD Million)
11.1. Middle East & Africa Pharmacogenomics Market Overview, 2017 - 2030 (USD Million)
11.1.1. Market Size and projections, 2017 - 2030 (USD Million)
11.1.2. Middle East & Africa Pharmacogenomics Market Overview, By Technology, 2017 - 2030 (USD Million)
11.1.3. Middle East & Africa Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
11.1.4. Middle East & Africa Pharmacogenomics Market Overview, By Countries, 2017 - 2030 (USD Million)
11.1.4.1. GCC
11.1.4.1.1. Market Size and projections, 2017 - 2030 (USD Million)
11.1.4.1.2. GCC Pharmacogenomics Market Overview, By Technology, 2017 - 2030 (USD Million)
11.1.4.1.3. GCC Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
11.1.4.2. South Africa
11.1.4.2.1. Market Size and projections, 2017 - 2030 (USD Million)
11.1.4.2.2. South Africa Pharmacogenomics Market Overview, By Technology, 2017 - 2030 (USD Million)
11.1.4.2.3. South Africa Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
11.1.4.3. Rest of Middle East & Africa
11.1.4.3.1. Market Size and projections, 2017 - 2030 (USD Million)
11.1.4.3.2. Rest of Middle East & Africa Pharmacogenomics Market Overview, By Technology, 2017 - 2030 (USD Million)
11.1.4.3.3. Rest of Middle East & Africa Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
Chapter 12. South America Pharmacogenomics Market Overview, By Countries, 2017 - 2030 (USD Million)
12.1. South America Pharmacogenomics Market Overview, 2017 - 2030 (USD Million)
12.1.1. Market Size and projections, 2017 - 2030 (USD Million)
12.1.2. South America Pharmacogenomics Market Overview, By Technology, 2017 - 2030 (USD Million)
12.1.3. South America Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
12.1.4. South America Pharmacogenomics Market Overview, By Countries, 2017- 2030 (USD Million)
12.1.5. Brazil
12.1.5.1. Market Size and projections, 2017 - 2030 (USD Million)
12.1.5.2. Brazil Pharmacogenomics Market Overview, By Technology, 2017 - 2030 (USD Million)
12.1.5.3. Brazil Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
12.1.6. Argentina
12.1.6.1. Market Size and projections, 2017 - 2030 (USD Million)
12.1.6.2. Argentina Pharmacogenomics Market Overview, By Technology, 2017 - 2030 (USD Million)
12.1.6.3. Argentina Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
12.1.7. Rest of South America
12.1.7.1. Market Size and projections, 2017 – 2030
12.1.7.2. Rest of South America Pharmacogenomics Market Overview, By Technology, 2017 - 2030 (USD Million)
12.1.7.3. Rest of South America Pharmacogenomics Market Overview, By Application, 2017 - 2030 (USD Million)
Chapter 13. Competitive Landscape
13.1. Competitive environment, 2021
13.2. Strategic framework
13.2.1. Partnership/agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New Size development
Chapter 14. Key Vendor Analysis
14.1. Admera Health
14.1.1. Company overview
14.1.2. Financial performance
14.1.3. Product Benchmarking
14.1.4. Recent initiatives
14.1.5. SWOT analysis
14.2. ARMOR
14.2.1. Company overview
14.2.2. Financial performance
14.2.3. Product Benchmarking
14.2.4. Recent initiatives
14.2.5. SWOT analysis
14.3. Abbott Laboratories.
14.3.1. Company overview
14.3.2. Financial performance
14.3.3. Product Benchmarking
14.3.4. Recent initiatives
14.4. Agilent Technologies
14.5. Novartis AG
14.6. Dynamic DNA Laboratories
14.7. Empire Genomics, LLC.
14.8. F. Hoffmann-La Roche Ltd.
14.9. Illumina, Inc.
14.10. Others
Chapter 15. Sourcing Strategy and Downstream Buyers
15.1. Pharmacogenomics Market Industrial Chain Analysis
15.2. Downstream Buyers
Chapter 16. Marketing Strategy Analysis, Distributors/Traders
16.1. Marketing Channel
16.1.1. Direct Marketing
16.1.2. Indirect Marketing
16.1.3. Marketing Channel Development Trend
16.2. Market Positioning
16.2.1. Pricing Strategy
16.2.2. Brand Strategy
16.2.3. Target Client
16.3. Distributors/Traders List
Chapter 17. Market Effect Factors Analysis
17.1. Product Progress/Risk
17.1.1. Substitutes Threat
17.1.2. Product Progress in Related Size
17.2. Consumer Needs/Customer Preference Change
17.3. Economic/Political Environmental Change
Chapter 18. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Application of Suppliers
5. Application of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Pharmacogenomics Market share, By Technology, 2021 & 2030 (%)
10. Global Pharmacogenomics Market share, by DNA Sequencing, By Technology, 2017 - 2030 (USD Million)
11. Global Pharmacogenomics Market share, by Microarray, By Technology, 2017 - 2030 (USD Million)
12. Global Pharmacogenomics Market share, by Polymerase Chain Reaction, By Technology, 2017 - 2030 (USD Million)
13. Global Pharmacogenomics Market share, by Electrophoresis, By Technology, 2017 - 2030 (USD Million)
14. Global Pharmacogenomics Market share, by Mass Spectrometry, By Technology, 2017 - 2030 (USD Million)
15. Global Pharmacogenomics Market share, by Others, By Technology, 2017 - 2030 (USD Million)
16. Global Pharmacogenomics Market share, By Application, 2021 & 2030 (%)
17. Global Pharmacogenomics Market share, by Drug Discovery, By Application, 2017 - 2030 (USD Million)
18. Global Pharmacogenomics Market share, by Neurology, By Application, 2017 - 2030 (USD Million)
19. Global Pharmacogenomics Market share, by Oncology, By Application, 2017 - 2030 (USD Million)
20. Global Pharmacogenomics Market share, by Pain Management, By Application, 2017 - 2030 (USD Million)
21. Global Pharmacogenomics Market share, by Others, By Application, 2017 - 2030 (USD Million)
22. Global Pharmacogenomics Market share, by region, 2021 & 2030 (%)
23. Global Pharmacogenomics Market share, by region, 2017 - 2030(USD Million)
24. North America Pharmacogenomics Market, 2017 - 2030(USD Million)
25. North America Pharmacogenomics Market share, by Countries, 2021 & 2030 (%)
26. U.S. Pharmacogenomics Market, 2017 - 2030(USD Million)
27. Canada Pharmacogenomics Market, 2017 - 2030(USD Million)
28. Mexico Pharmacogenomics Market, 2017 - 2030(USD Million)
29. Europe Pharmacogenomics Market, 2017 - 2030(USD Million)
30. Europe Pharmacogenomics Market share, by Countries, 2021 & 2030 (%)
31. Spain Pharmacogenomics Market, 2017 - 2030(USD Million)
32. UK Pharmacogenomics Market, 2017 - 2030(USD Million)
33. Italy Pharmacogenomics Market, 2017 - 2030(USD Million)
34. Germany Pharmacogenomics Market, 2017 - 2030(USD Million)
35. France Pharmacogenomics Market, 2017 - 2030(USD Million)
36. Rest of Europe Pharmacogenomics Market, 2017 - 2030(USD Million)
37. Asia-Pacific Pharmacogenomics Market, 2017 - 2030(USD Million)
38. Asia-Pacific Pharmacogenomics Market share, by Countries, 2021 & 2030 (%)
39. China Pharmacogenomics Market, 2017 - 2030(USD Million)
40. India Pharmacogenomics Market, 2017 - 2030(USD Million)
41. Australia Pharmacogenomics Market, 2017 - 2030(USD Million)
42. Japan Pharmacogenomics Market, 2017 - 2030(USD Million)
43. Rest of Asia-Pacific Pharmacogenomics Market, 2017 - 2030(USD Million)
44. Middle East & Africa Pharmacogenomics Market, 2017 - 2030(USD Million)
45. Middle East & Africa Pharmacogenomics Market share, by Countries, 2021 & 2030 (%)
46. GCC Pharmacogenomics Market, 2017 - 2030(USD Million)
47. South Africa Pharmacogenomics Market, 2017 - 2030(USD Million)
48. Rest of Middle East & Africa Pharmacogenomics Market, 2017 - 2030(USD Million)
49. South America Pharmacogenomics Market, 2017 - 2030(USD Million)
50. Brazil Pharmacogenomics Market, 2017 - 2030(USD Million)
51. Argentina Pharmacogenomics Market, 2017 - 2030(USD Million)
52. Rest of South America Pharmacogenomics Market, 2017 - 2030(USD Million)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Pharmacogenomics Market, 2017-2030 (USD Million)
4. Global Pharmacogenomics Market requirement, by country, 2017-2030, (USD Million)
5. North America Pharmacogenomics Market, By Technology, 2017-2030 (USD Million)
6. North America Pharmacogenomics Market, By Application, 2017-2030 (USD Million)
7. Europe Pharmacogenomics Market, By Technology, 2017-2030 (USD Million)
8. Europe Pharmacogenomics Market, By Application, 2017-2030 (USD Million)
9. Asia Pacific Pharmacogenomics Market, By Technology, 2017-2030 (USD Million)
10. Asia Pacific Pharmacogenomics Market, By Application, 2017-2030 (USD Million)
11. Middle East & Africa Pharmacogenomics Market, By Technology, 2017-2030 (USD Million)
12. Middle East & Africa Pharmacogenomics Market, By Application, 2017-2030 (USD Million)
13. South America Pharmacogenomics Market, By Technology, 2017-2030 (USD Million)
14. South America Pharmacogenomics Market, By Application, 2017-2030 (USD Million)
15. Global Pharmacogenomics Market, Company Market Share, 2021 - 2030 (%)
16. Admera Health: Product Benchmarking
17. Admera Health: Financial Performance
18. ARMOR: Product Benchmarking
19. ARMOR: Financial Performance
20. Abbott Laboratories.: Product Benchmarking
21. Abbott Laboratories.: Financial Performance
22. Agilent Technologies: Product Benchmarking
23. Agilent Technologies: Financial Performance
24. Novartis AG: Product Benchmarking
25. Novartis AG: Financial Performance
26. Dynamic DNA Laboratories: Product Benchmarking
27. Dynamic DNA Laboratories: Financial Performance
28. Empire Genomics, LLC.: Product Benchmarking
29. Empire Genomics, LLC.: Financial Performance
30. F. Hoffmann-La Roche Ltd.: Product Benchmarking
31. F. Hoffmann-La Roche Ltd.: Financial Performance
32. Illumina, Inc.; Product Benchmarking
33. Illumina, Inc.: Financial Performance
ARE YOU SEEKING COMPREHENSIVE INSIGHT ON
VARIOUS MARKETS?
CONTACT OUR EXPERTS
TODAY
Speak to an
Expert
Global Pharmacogenomics Market Size
- July-2022